<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-XI0P5FDN</identifier><date>2014</date><creator>Adamič, Katja</creator><creator>Bajrović, Nisera</creator><creator>Eržen, Renato</creator><creator>Kopač, Peter</creator><creator>Korošec, Peter</creator><creator>Košnik, Mitja</creator><creator>Lalek, Nika</creator><creator>Zidarn, Mihaela</creator><relation>documents/doc/X/URN_NBN_SI_doc-XI0P5FDN_001.pdf</relation><relation>documents/doc/X/URN_NBN_SI_doc-XI0P5FDN_001.txt</relation><format format_type="volume">23</format><format format_type="issue">3</format><format format_type="type">article</format><format format_type="extent">str. 57-61</format><identifier identifier_type="ISSN">1318-4458</identifier><identifier identifier_type="URN">1318-4458</identifier><identifier identifier_type="COBISSID">277134336</identifier><language>eng</language><publisher>Slovene Welding Society</publisher><source>Acta dermatovenerologica Alpina, Pannonica et Adriatica</source><rights>InC</rights><subject language_type_id="slv">dermatologija</subject><subject language_type_id="slv">omalizumab</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">urtikarija</subject><subject language_type_id="slv">zdravljenje</subject><title>Omalizumab in chronic urticaria</title><title>our experience and literature review</title></Record>